[Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D002462:Cell Membrane; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000209:etiology*; D004195:Disease Models, Animal; D005688:Galactosamine / Q000009:adverse effects*; D009708:Nucleotidases / Q000097:blood; D010088:Oxidoreductases / Q000097:blood; D051381:Rats
D005688:Galactosamine; D010088:Oxidoreductases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D009708:Nucleotidases
Galaktosamin-Hepatitis: Schädigung der Plasmamembran der leberzelle nach Gabe von D-Galaktosamin.